A federal judge this week blocked the Trump administration’s rule requiring pharmaceutical companies include a drug’s list price in television ads, STAT reports.
The decision argues Health and Human Services (HHS) had insufficient authority to force drugmakers to disclose list prices in TV ads, and that the rule violates companies’ First Amendment rights.
While judge Amit Mehta, according to the report, said HHS did not have the authority to require those price disclosures, he did not address First Amendment claims.
“To be sure, the costs imposed by the … Rule amount to a rounding error for the pharmaceutical industry,” Mehta wrote. “But that argument misses the point. It is the agency’s incursion into a brand-new regulatory environment, and the rationale for it, that make the Rule so consequential.”
To read the full report on STAT, click here.